Monday, November 23, 2020
Pharma

Latest articles in Pharma

St. Jude scientists identify possible COVID-19 treatment in the lab

If validated, the discovery by St Jude scientists could offer real tools to deal with hyperinflammatory immune responses, one of the leading causes of death in Covid-19 infections

First Drug Synthesized by AI Goes into Clinical Trials

If all goes well, thanks to artificial intelligence, we may soon have a new AI-synthesized drug capable of assisting OCD patients in managing their symptoms and thus leading normal lives.

Oriahnn; A Drug to Stop Heavy Periods for Women With Fibroids

Oriahnn™ comes packaged as a daily oral medication giving women the options to avoid surgery, procedure, or a birth control method.

Perrigo Voluntarily Recalls Albuterol Sulfate Inhalation Aerosol

A voluntary U.S. nationwide recall of albuterol sulfate inhalation aerosol to the retail level after previously halting production and distribution.

COVID-19 Vaccine Talk; Here Is Why We Need to Tap the Brakes

  Covid-19 cases are once again on the rise. Hospitalizations are increasing. The prospect of a brutal third wave seems...

Purdue Reformulated OxyContin to Reduce Abuse — Did They Succeed?

OxyContin was neither superior to old-fashioned immediate-release oxycodone, a cheaper generic, nor did it offer any advantage over other opioids like morphine.

Free Drive-thru Flu Shot Clinics Across Los Angeles County

L.A. Care Health Plan and Blue Shield of California Promise Health Plan's network of Community Resource Centers are offering drive-thru flu shot clinics across Los Angeles County

Treatment for Schizophrenia and Bipolar I Disorder Gets Vote of Support

The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.

TaiGen files US IND for its influenza antiviral TG-1000

TaiGen Biotechnology Company, announced today that it has filed an IND application with the US FDA for its influenza antiviral TG-1000.

FDA Approves Drug Combination for Treating Mesothelioma

First approval in 16 years for mesothelioma, a type of cancer caused by inhaling asbestos fibers SILVER SPRING, Md., Oct. 2,...

Uqora Develops the First Non-Antibiotic Treatment Option for UTIs

The new drug program aims to decrease the amount of UTIs that would otherwise require antibiotic intervention.

Phexxi; Have You Heard About This New Hormone-Free Contraceptive?

She is sick of using birth control, but now is not the right time to get pregnant. The “pull...

Editors Choice

Colchicine Shows 48% Reduction in Future Cardio Issues for Heart Attack...

Early, in-hospital treatment with colchicine reduces the odds of future cardiovascular problems by 48% in people who have just survived a heart attack

Oriahnn; A Drug to Stop Heavy Periods for Women With Fibroids

Oriahnn™ comes packaged as a daily oral medication giving women the options to avoid surgery, procedure, or a birth control method.

Dallas researchers aim to accelerate women’s health clinical trials

Local Dallas Fort Worth researchers are combining critical components that can help accelerate research for women’s health trials